Fang Liu, MD
Children's Hospital of Fudan University
5
0
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Michael B Cook, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Frantz THIESSARD, MD
University Hospital Bordeaux, France
Shared therapeutic areas:
Qi Zhu, MD
Lantheus Medical Imaging
Shared therapeutic areas:
Tsae Jyy Wang, PhD
National Taipei University of Nursing and Health Sciences
Shared therapeutic areas:
Paul N Pfeiffer, MD MS
VA Ann Arbor Healthcare System, Ann Arbor, MI
Shared therapeutic areas:
Wim Van Biesen, PhD
University Hospital, Ghent
Shared therapeutic areas:
Mario FL Gaudino, MD
Weill Cornell Medicine NewYork Presbyterian Hospital
Shared therapeutic areas:
Federico Longhini, MD
Magna graecia University
Shared therapeutic areas:
Anne Kuitunen, MD, PhD
Tampere University Hospital
Shared therapeutic areas:
Kwang-No LEE
Ajou University School of Medicine
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
All 5 trials loaded